Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179022-17-000001
Filing Date
2017-01-20
Accepted
2017-01-20 16:46:15
Documents
1
Period of Report
2017-01-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5771
  Complete submission text file 0001179022-17-000001.txt   7351
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PRO-PHARMACEUTICALS INC 7 WELLS AVENUE SUITE 34 NEWTON MA 02459
Business Address 617-559-0033
ZUCCONI THEODORE DANIEL (Reporting) CIK: 0001413699 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 17538957